Current
$135B
5-Year Average
$111B
All-Time High
$163B
All-Time Low
$21.8B
Market cap daily chart for AstraZeneca (AZN)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for AstraZeneca (AZN) from 2017 to 2026
Latest: -1.4%
Market Cap history table for AstraZeneca (AZN) from 1993 to 2026
| 2026 | $135B | -1.4% | -$1.89B | ||
| 2025 | $137B | +34.9% | +$35.5B | ||
| 2024 | $102B | -3.2% | -$3.41B | ||
| 2023 | $105B | -1.2% | -$1.25B | ||
| 2022 | $106B | +28.5% | +$23.6B | ||
| 2021 | $82.7B | +24.7% | +$16.4B | ||
| 2020 | $66.3B | +0.9% | +$606M | ||
| 2019 | $65.7B | +36.5% | +$17.6B | ||
| 2018 | $48.1B | +9.5% | +$4.16B | ||
| 2017 | $44B | +28.9% | +$9.87B | ||
| 2016 | $34.1B | -20.3% | -$8.69B | ||
| 2015 | $42.8B | -3.8% | -$1.69B | ||
| 2014 | $44.5B | +20.5% | +$7.58B | ||
| 2013 | $36.9B | +23.5% | +$7.02B | ||
| 2012 | $29.9B | -5.6% | -$1.76B | ||
| 2011 | $31.6B | -5.3% | -$1.76B | ||
| 2010 | $33.4B | -1.9% | -$636M | ||
| 2009 | $34B | +14.2% | +$4.22B | ||
| 2008 | $29.8B | -7.1% | -$2.26B | ||
| 2007 | $32.1B | -23.3% | -$9.73B | ||
| 2006 | $41.8B | +6.3% | +$2.48B | ||
| 2005 | $39.3B | +29.2% | +$8.88B | ||
| 2004 | $30.4B | -25.0% | -$10.1B | ||
| 2003 | $40.6B | +33.3% | +$10.1B | ||
| 2002 | $30.4B | -25.7% | -$10.5B | ||
| 2001 | $41B | -10.0% | -$4.56B | ||
| 2000 | $45.5B | +22.8% | +$8.45B | ||
| 1999 | $37.1B | +77.0% | +$16.1B | ||
| 1998 | $20.9B | +22.4% | +$3.83B | ||
| 1997 | $17.1B | +29.1% | +$3.86B | ||
| 1996 | $13.3B | +44.0% | +$4.05B | ||
| 1995 | $9.2B | +41.9% | +$2.72B | ||
| 1994 | $6.48B | +22.9% | +$1.21B | ||
| 1993 | $5.28B | — | — |
- 2026$135B-1.4%
- 2025$137B+34.9%
- 2024$102B-3.2%
- 2023$105B-1.2%
- 2022$106B+28.5%
- 2021$82.7B+24.7%
- 2020$66.3B+0.9%
- 2019$65.7B+36.5%
- 2018$48.1B+9.5%
- 2017$44B+28.9%
- 2016$34.1B-20.3%
- 2015$42.8B-3.8%
- 2014$44.5B+20.5%
- 2013$36.9B+23.5%
- 2012$29.9B-5.6%
- 2011$31.6B-5.3%
- 2010$33.4B-1.9%
- 2009$34B+14.2%
- 2008$29.8B-7.1%
- 2007$32.1B-23.3%
- 2006$41.8B+6.3%
- 2005$39.3B+29.2%
- 2004$30.4B-25.0%
- 2003$40.6B+33.3%
- 2002$30.4B-25.7%
- 2001$41B-10.0%
- 2000$45.5B+22.8%
- 1999$37.1B+77.0%
- 1998$20.9B+22.4%
- 1997$17.1B+29.1%
- 1996$13.3B+44.0%
- 1995$9.2B+41.9%
- 1994$6.48B+22.9%
- 1993$5.28B—
Market Cap values are taken from AstraZeneca's reported income statements (share counts) and end-of-day prices (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported market cap is $148B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for AstraZeneca (AZN) came in at $135B – edged down 1.4% year-over-year.
Over 2021–2026 (5 years), AstraZeneca market cap expanded at a +10.3% compound annual rate, with mixed annual results across the window.
Between 2025 and 2026, AstraZeneca market cap edged down 1.4%, falling from $137B to $135B.
2025 marks the peak market cap at $137B, with the historical low of $5.28B recorded in 1993.
AstraZeneca Market Cap by Year
AstraZeneca Market Cap 2026: $135B
AstraZeneca market cap in 2026 was $135B, edged down 1.4% below 2025.
AstraZeneca Market Cap 2025: $137B
2025's market cap for AstraZeneca came in at $137B, surged 34.9% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Market Cap 2024: $102B
AstraZeneca posted market cap of $102B in 2024, edged down 3.2% below 2023.
AstraZeneca Market Cap 2023: $105B
In 2023, AstraZeneca reported market cap of $105B, edged down 1.2% below 2022.
AstraZeneca Market Cap 2022: $106B
AstraZeneca market cap in 2022 was $106B.
See more financial history for AstraZeneca (AZN).
Sector peers by Market Cap
Healthcare peers of AstraZeneca (AZN), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on AZN
Market Cap — 10 rounds, every one of them AZN against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.18% TTM
- Dividend Profile1.85% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.